BRIEF-Advaxis announces FDA acceptance of IND for groundbreaking personalized neoepitope immunotherapy … – Reuters
|
BRIEF-Advaxis announces FDA acceptance of IND for groundbreaking personalized neoepitope immunotherapy …
Reuters Reuters is the news and media division of Thomson Reuters. Thomson Reuters is the world’s largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news … |
|
Advaxis Announces FDA Acceptance of IND for Groundbreaking Personalized Neoepitope Immunotherapy, ADXS-NEO
Yahoo Finance This ground-breaking IND paves the way for bringing a new precision immunotherapy for the treatment of cancers into the clinic this year. ADXS-NEO employs Advaxis’ proprietary Listeria monocytogenes (Lm)-based antigen delivery technology, its Lm … |
Christian Post |
Cancer Cure News 2017: New Gene Therapy Treatment May Extend Life of Terminal Patients
Christian Post In fact, U.S. pharmaceutical company Kite Pharma has recently released the groundbreaking results of their six-month gene therapy trial in which terminal cancer patients were found to be in complete remission after just a single round of treatment. ‘Extraordinary’ new cancer drug appears to cure a third of terminal lymphoma patients in small studyThe Independent |
Xconomy |
Ingeneron Gets $20M From Sanford Health For Stem Cell Treatment
Xconomy Houston—Ingeneron, a Houston-based developer of a stem cell-based technology, announced Monday that it has raised $20 million from strategic partner Sanford Health. Ingeneron is developing a stem cell-based system meant to help patients recover from … |
KRQE News 13 |
Gene therapy to fight a blood cancer succeeds in major study
KRQE News 13 In this May 2016 photo provided by Kite Pharma, cell therapy specialists at the company’s manufacturing facility in El Segundo, Calif., prepare blood cells from a patient to be engineered in the lab to fight cancer. The experimental gene therapy … |
FOX31 Denver |
Sickle cell anemia patient ‘cured’ by gene therapy, doctors say
FOX31 Denver Leboulch and his colleagues are using the same genetic therapy to treat a similar disease called thalassemia, another inherited blood disorder in which patients have less hemoglobin and fewer red blood cells than normal. Severe forms require regular … Doctors reverse teen’s sickle cell disease with innovative gene therapyFox News Scientists Reverse Sickle Cell Disease for the First Time Using Gene TherapyScienceAlert Sickle cell gene therapy: ‘It gives me joy and hope’BBC News Futurism –Chicago Tribune all 51 news articles » |
KMAland |
Developer of CRISPR technology to speak at biotech forum in Ankeny
KMAland One of those issues is CRISPR technology. Its technology replacing DNA letters in an organism’s genome. Dr. Feng Zhang is a professor at the Broad Institute at Harvard and MIT. Hrdlicka says Zhang was raised in Des Moines and was the pioneer behind … |